[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"skill:01M7AKMS5K7GMFPPDB2C5223FT":3,"skill-same:01M7AKMS5K7GMFPPDB2C5223FT":48},{"skillNo":4,"name":5,"nameZh":6,"description":7,"descriptionZh":6,"repositoryFullName":8,"ownerLogin":9,"ownerAvatarUrl":10,"ownerAccountNo":11,"ownerDisplayName":12,"repositoryNo":13,"starsCount":14,"licenseSpdxId":15,"licenseFileUrl":6,"sourceHtmlUrl":16,"categories":17,"keywords":18,"publishedAt":19,"linkOnly":20,"markdownContent":21,"markdownBody":22,"frontMatter":23,"refName":24,"commitSha":25,"skillDirectory":26,"forksCount":27,"repositoryHtmlUrl":28,"repositoryHomepageUrl":29,"ownerHtmlUrl":30,"ownerBlogUrl":31,"ownerDescription":32,"updatedAt":33,"install":34,"resources":47},"01M7AKMS5K7GMFPPDB2C5223FT","biomed-structural-systems-biology-and-pharmacology",null,"Use when modelling biological structure or dynamics: structural biology including protein structure determination and prediction, systems biology and network modelling, pharmacokinetics and pharmacodynamics including compartment models, clearance and dose-response, and physiological models of the cardiovascular, respiratory and metabolic systems.","the-vibey-project\u002Fvibey","the-vibey-project","https:\u002F\u002Favatars.githubusercontent.com\u002Fu\u002F329298758?v=4","01M7AJHGZ9722CTJ4JNQZVRH0Q","the vibey project","01M7AJHGZVMG2K7TGXQ6XFHVG3",5,"MIT","https:\u002F\u002Fgithub.com\u002Fthe-vibey-project\u002Fvibey\u002Fblob\u002Fdevelop\u002Fsrc\u002Fvibey_tools\u002Fskills\u002Fplugins\u002Fbiomedical-engineering-technical\u002Fskills\u002Fbiomed-structural-systems-biology-and-pharmacology\u002FSKILL.md",[],[],"2026-11-15 14:19:17",false,"---\nname: biomed-structural-systems-biology-and-pharmacology\ndescription: \"Use when modelling biological structure or dynamics: structural biology including protein structure determination and prediction, systems biology and network modelling, pharmacokinetics and pharmacodynamics including compartment models, clearance and dose-response, and physiological models of the cardiovascular, respiratory and metabolic systems.\"\n---\n\n# Biomedical Engineering: Structural Biology, Systems Biology, PK\u002FPD, and Physiological Models\n\n> **Part 3 of 5** of the *Biomedical Engineering* reference (plugin `biomedical-engineering-technical`), covering §6–§9. Sibling skills: `biomed-signals-and-medical-imaging` (§0–§2), `biomed-clinical-data-ml-and-bioinformatics` (§3–§5), `biomed-biomechanics-devices-and-biostatistics` (§10–§15), `biomed-reference` (§16–§20). Section numbers are shared across the set; a reference written as §N → `skill` points into that sibling skill.\n>\n> **Currency:** The physics, physiology and mathematics are stable; tool and pipeline recommendations shift slowly.\n\n> **Scope note.** This is the engineering and science. **Regulatory pathways, quality\n> systems, and lifecycle process are deliberately excluded** — they're a separate subject\n> and they'd swamp the technical content.\n>\n> **⚠️ GOTCHA** boxes mark where a silent wrong answer is produced — which in this domain\n> is the dangerous failure mode, not a crash.\n>\n> **The three technical facts that recur everywhere below:**\n> 1. **⚠️ Biological signals are non-stationary, and most DSP assumes stationarity.** Every\n>    windowing choice is an assumption about how long the physiology holds still (§1 → `biomed-signals-and-medical-imaging`).\n> 2. **⚠️ Prevalence governs predictive value.** Sensitivity and specificity are properties\n>    of a test; PPV is a property of a test *in a population*. Confusing them is the single\n>    most common quantitative error in the field (§4.1 → `biomed-clinical-data-ml-and-bioinformatics`).\n> 3. **⚠️ Biological variability is the signal's competitor.** Between-subject variance\n>    usually exceeds the effect you're measuring, which is why normalization,\n>    within-subject designs, and mixed-effects models dominate (§15 → `biomed-biomechanics-devices-and-biostatistics`).\n\n---\n\n## §6. Structural Biology\n\n**Protein structure**: primary (sequence) → secondary (α-helix, β-sheet, from backbone\nφ\u002Fψ angles — ⚠️ **Ramachandran plot shows the allowed regions**) → tertiary → quaternary.\n\n**Determination**: **X-ray crystallography** (⚠️ **resolution in Å; requires crystals, and\nthe phase problem**), **cryo-EM** (⚠️ **the resolution revolution — now routinely\nsub-3 Å, no crystals needed**), **NMR** (solution state, size-limited).\n\n**Prediction**: **AlphaFold2\u002F3** changed the field — ⚠️ **read the confidence metrics\nproperly. pLDDT is per-residue confidence (>90 very high, \u003C50 likely disordered); PAE is\nthe predicted aligned error between residue pairs and is what tells you whether relative\ndomain positions are trustworthy.** **A high-pLDDT structure with high inter-domain PAE\nmeans good domains, unreliable arrangement.**\n\n**⚠️ And the standing caveats**: predicted structures are **single static conformations**;\nthey do not give you the conformational ensemble, ligand-bound states, or the effects of\npoint mutations reliably.\n\n**Molecular dynamics**: integrate Newton's equations with a **force field** (AMBER,\nCHARMM, OPLS) at **~2 fs timesteps** — ⚠️ **which is the fundamental problem: biologically\ninteresting events take microseconds to milliseconds, i.e. 10⁹–10¹² steps.** Enhanced\nsampling (replica exchange, metadynamics, umbrella sampling) exists to bridge it.\n**Docking** (AutoDock Vina, Glide) for binding pose; ⚠️ **scoring functions predict pose\nmuch better than they predict affinity.**\n\n---\n\n## §7. Systems Biology\n\n**Mass-action kinetics**: `d[X]\u002Fdt = Σ (production) − Σ (consumption)`.\n**Michaelis–Menten**: `v = V_max[S]\u002F(K_m + [S])` — ⚠️ **valid under the quasi-steady-state\nassumption ([S] ≫ [E]), which is violated inside cells more often than people assume.**\n**Hill equation**: `θ = [L]^n\u002F(K_d + [L]^n)` — cooperativity, and `n` is the steepness of\nthe switch.\n\n**Network motifs** that recur and what they do: **negative feedback** (homeostasis, noise\nreduction), **positive feedback** (⚠️ **bistability — a switch**), **coherent feedforward\nloop** (⚠️ **persistence detection: filters transient inputs**), **incoherent feedforward\nloop** (pulse generation, fold-change detection), **oscillators** (negative feedback plus\ndelay — circadian clocks, p53).\n\n**Flux balance analysis** for metabolism: `S·v = 0` at steady state, then maximize an\nobjective (usually growth) by linear programming subject to flux bounds. ⚠️ **No kinetic\nparameters needed, which is why it scales to genome-scale models — and why it can't\npredict dynamics.**\n\n**Stochastic simulation** — **Gillespie's algorithm** for exact trajectories when molecule\ncounts are low. ⚠️ **Necessary because transcription factors can number in the tens per\ncell, where the deterministic ODE is simply wrong.**\n\n---\n\n## §8. PK\u002FPD\n\n**[DURABLE] The quantitative core of dosing.**\n\n**One-compartment IV bolus**: `C(t) = (D\u002FV)·e^(−kt)`, with **half-life** `t½ = ln2\u002Fk` and\n**clearance** `CL = k·V`.\n**⚠️ Clearance is the physiologically meaningful parameter** — volume of plasma cleared per\nunit time. **Half-life is derived from CL and V, not fundamental.**\n\n**Steady state on repeated dosing**:\n```\nC_ss,avg = (F · D) \u002F (CL · τ)\nAccumulation ratio = 1\u002F(1 − e^(−kτ))\n⚠️ Steady state is reached at ~4–5 half-lives, regardless of dose or interval\n```\n**Loading dose** `= C_target × V \u002F F` — ⚠️ **because reaching steady state otherwise takes\n4–5 half-lives, which for amiodarone (t½ ≈ 58 days) is months.**\n\n**Absorption**: bioavailability `F`, **first-pass metabolism**, `T_max`, `C_max`.\n**Distribution**: `V_d` — ⚠️ **an apparent volume, not physical; it can exceed total body\nwater enormously for tissue-bound drugs.**\n**Elimination**: usually first-order; ⚠️ **but saturable (Michaelis–Menten) elimination\nmakes concentration rise disproportionately with dose — phenytoin and ethanol are the\nclassic examples, and this is where dosing errors become toxic.**\n\n**PD**: `E = E_max·C^n\u002F(EC₅₀^n + C^n)`. **Direct-effect, effect-compartment (for\nhysteresis), and indirect-response models.**\n\n**Population PK (NONMEM\u002Fnlmixr\u002FMonolix)** — **nonlinear mixed effects**: fixed effects\n(typical values), **random effects** (between-subject variability, usually log-normal:\n`P_i = P_typ · e^(η_i)`), and residual error. ⚠️ **Covariates (weight, renal function,\nage) explain part of the between-subject variance — allometric scaling `CL ∝ WT^0.75` is\nthe standard starting point.**\n\n**PBPK** — physiologically-based models with actual organ compartments, blood flows, and\npartition coefficients. ⚠️ **Used for extrapolation where you have no data: paediatrics,\norgan impairment, drug-drug interactions.**\n\n---\n\n## §9. Physiological Models\n\n**⚠️ Hodgkin–Huxley (1952)** — still the foundation of computational neuroscience:\n```\nC_m dV\u002Fdt = I_ext − ḡ_Na m³h (V−E_Na) − ḡ_K n⁴ (V−E_K) − ḡ_L(V−E_L)\ndx\u002Fdt = α_x(V)(1−x) − β_x(V)x        for x ∈ {m, h, n}\n```\n**⚠️ The gating variables are the insight**: `m³h` and `n⁴` — activation raised to a power\n(multiple independent gates) times inactivation. **Four coupled nonlinear ODEs producing an\naction potential from first principles.**\n\n**Reduced models**: **FitzHugh–Nagumo** (2D, captures excitability and the phase-plane\ngeometry), **integrate-and-fire** and **Izhikevich** (⚠️ **computationally cheap enough for\nlarge networks, and reproduces most observed spiking patterns with four parameters**).\n\n**Nernst and GHK**:\n```\nE_ion = (RT\u002FzF)·ln([ion]_out\u002F[ion]_in)      ⚠️ ~61.5\u002Fz · log₁₀(ratio) mV at 37 °C\n```\n\n**Cardiac electrophysiology**: ionic models (Luo-Rudy, ten Tusscher, O'Hara-Rudy) coupled\nby the **monodomain or bidomain** reaction-diffusion equation for tissue propagation.\n⚠️ **Reentry and spiral waves are the mechanism of many arrhythmias, and they emerge from\nthe tissue equations, not the cell model.**\n\n**Hemodynamics**: **Windkessel** — the 2-element model is `C dP\u002Fdt + P\u002FR = Q(t)`, a\ncapacitor-resistor analogue of arterial compliance and peripheral resistance.\n**Poiseuille**: `Q = πΔP r⁴\u002F(8µL)` — ⚠️ **the `r⁴` is why a small stenosis has enormous\nconsequence; halving radius cuts flow 16-fold.**\n**Reynolds number** `Re = ρvD\u002Fµ` — ⚠️ **blood flow is mostly laminar (Re \u003C 2000); turbulence\nappears at stenoses and valves and is what a bruit or murmur is.**\n**⚠️ Blood is non-Newtonian** — shear-thinning, with the Fåhræus–Lindqvist effect reducing\napparent viscosity in small vessels.\n\n**Respiratory**: compliance `C = ΔV\u002FΔP`, resistance, the **equation of motion**\n`P = V\u002FC + R·V̇ + PEEP`, and dead space via the Bohr equation.\n","# Biomedical Engineering: Structural Biology, Systems Biology, PK\u002FPD, and Physiological Models\n\n> **Part 3 of 5** of the *Biomedical Engineering* reference (plugin `biomedical-engineering-technical`), covering §6–§9. Sibling skills: `biomed-signals-and-medical-imaging` (§0–§2), `biomed-clinical-data-ml-and-bioinformatics` (§3–§5), `biomed-biomechanics-devices-and-biostatistics` (§10–§15), `biomed-reference` (§16–§20). Section numbers are shared across the set; a reference written as §N → `skill` points into that sibling skill.\n>\n> **Currency:** The physics, physiology and mathematics are stable; tool and pipeline recommendations shift slowly.\n\n> **Scope note.** This is the engineering and science. **Regulatory pathways, quality\n> systems, and lifecycle process are deliberately excluded** — they're a separate subject\n> and they'd swamp the technical content.\n>\n> **⚠️ GOTCHA** boxes mark where a silent wrong answer is produced — which in this domain\n> is the dangerous failure mode, not a crash.\n>\n> **The three technical facts that recur everywhere below:**\n> 1. **⚠️ Biological signals are non-stationary, and most DSP assumes stationarity.** Every\n>    windowing choice is an assumption about how long the physiology holds still (§1 → `biomed-signals-and-medical-imaging`).\n> 2. **⚠️ Prevalence governs predictive value.** Sensitivity and specificity are properties\n>    of a test; PPV is a property of a test *in a population*. Confusing them is the single\n>    most common quantitative error in the field (§4.1 → `biomed-clinical-data-ml-and-bioinformatics`).\n> 3. **⚠️ Biological variability is the signal's competitor.** Between-subject variance\n>    usually exceeds the effect you're measuring, which is why normalization,\n>    within-subject designs, and mixed-effects models dominate (§15 → `biomed-biomechanics-devices-and-biostatistics`).\n\n---\n\n## §6. Structural Biology\n\n**Protein structure**: primary (sequence) → secondary (α-helix, β-sheet, from backbone\nφ\u002Fψ angles — ⚠️ **Ramachandran plot shows the allowed regions**) → tertiary → quaternary.\n\n**Determination**: **X-ray crystallography** (⚠️ **resolution in Å; requires crystals, and\nthe phase problem**), **cryo-EM** (⚠️ **the resolution revolution — now routinely\nsub-3 Å, no crystals needed**), **NMR** (solution state, size-limited).\n\n**Prediction**: **AlphaFold2\u002F3** changed the field — ⚠️ **read the confidence metrics\nproperly. pLDDT is per-residue confidence (>90 very high, \u003C50 likely disordered); PAE is\nthe predicted aligned error between residue pairs and is what tells you whether relative\ndomain positions are trustworthy.** **A high-pLDDT structure with high inter-domain PAE\nmeans good domains, unreliable arrangement.**\n\n**⚠️ And the standing caveats**: predicted structures are **single static conformations**;\nthey do not give you the conformational ensemble, ligand-bound states, or the effects of\npoint mutations reliably.\n\n**Molecular dynamics**: integrate Newton's equations with a **force field** (AMBER,\nCHARMM, OPLS) at **~2 fs timesteps** — ⚠️ **which is the fundamental problem: biologically\ninteresting events take microseconds to milliseconds, i.e. 10⁹–10¹² steps.** Enhanced\nsampling (replica exchange, metadynamics, umbrella sampling) exists to bridge it.\n**Docking** (AutoDock Vina, Glide) for binding pose; ⚠️ **scoring functions predict pose\nmuch better than they predict affinity.**\n\n---\n\n## §7. Systems Biology\n\n**Mass-action kinetics**: `d[X]\u002Fdt = Σ (production) − Σ (consumption)`.\n**Michaelis–Menten**: `v = V_max[S]\u002F(K_m + [S])` — ⚠️ **valid under the quasi-steady-state\nassumption ([S] ≫ [E]), which is violated inside cells more often than people assume.**\n**Hill equation**: `θ = [L]^n\u002F(K_d + [L]^n)` — cooperativity, and `n` is the steepness of\nthe switch.\n\n**Network motifs** that recur and what they do: **negative feedback** (homeostasis, noise\nreduction), **positive feedback** (⚠️ **bistability — a switch**), **coherent feedforward\nloop** (⚠️ **persistence detection: filters transient inputs**), **incoherent feedforward\nloop** (pulse generation, fold-change detection), **oscillators** (negative feedback plus\ndelay — circadian clocks, p53).\n\n**Flux balance analysis** for metabolism: `S·v = 0` at steady state, then maximize an\nobjective (usually growth) by linear programming subject to flux bounds. ⚠️ **No kinetic\nparameters needed, which is why it scales to genome-scale models — and why it can't\npredict dynamics.**\n\n**Stochastic simulation** — **Gillespie's algorithm** for exact trajectories when molecule\ncounts are low. ⚠️ **Necessary because transcription factors can number in the tens per\ncell, where the deterministic ODE is simply wrong.**\n\n---\n\n## §8. PK\u002FPD\n\n**[DURABLE] The quantitative core of dosing.**\n\n**One-compartment IV bolus**: `C(t) = (D\u002FV)·e^(−kt)`, with **half-life** `t½ = ln2\u002Fk` and\n**clearance** `CL = k·V`.\n**⚠️ Clearance is the physiologically meaningful parameter** — volume of plasma cleared per\nunit time. **Half-life is derived from CL and V, not fundamental.**\n\n**Steady state on repeated dosing**:\n```\nC_ss,avg = (F · D) \u002F (CL · τ)\nAccumulation ratio = 1\u002F(1 − e^(−kτ))\n⚠️ Steady state is reached at ~4–5 half-lives, regardless of dose or interval\n```\n**Loading dose** `= C_target × V \u002F F` — ⚠️ **because reaching steady state otherwise takes\n4–5 half-lives, which for amiodarone (t½ ≈ 58 days) is months.**\n\n**Absorption**: bioavailability `F`, **first-pass metabolism**, `T_max`, `C_max`.\n**Distribution**: `V_d` — ⚠️ **an apparent volume, not physical; it can exceed total body\nwater enormously for tissue-bound drugs.**\n**Elimination**: usually first-order; ⚠️ **but saturable (Michaelis–Menten) elimination\nmakes concentration rise disproportionately with dose — phenytoin and ethanol are the\nclassic examples, and this is where dosing errors become toxic.**\n\n**PD**: `E = E_max·C^n\u002F(EC₅₀^n + C^n)`. **Direct-effect, effect-compartment (for\nhysteresis), and indirect-response models.**\n\n**Population PK (NONMEM\u002Fnlmixr\u002FMonolix)** — **nonlinear mixed effects**: fixed effects\n(typical values), **random effects** (between-subject variability, usually log-normal:\n`P_i = P_typ · e^(η_i)`), and residual error. ⚠️ **Covariates (weight, renal function,\nage) explain part of the between-subject variance — allometric scaling `CL ∝ WT^0.75` is\nthe standard starting point.**\n\n**PBPK** — physiologically-based models with actual organ compartments, blood flows, and\npartition coefficients. ⚠️ **Used for extrapolation where you have no data: paediatrics,\norgan impairment, drug-drug interactions.**\n\n---\n\n## §9. Physiological Models\n\n**⚠️ Hodgkin–Huxley (1952)** — still the foundation of computational neuroscience:\n```\nC_m dV\u002Fdt = I_ext − ḡ_Na m³h (V−E_Na) − ḡ_K n⁴ (V−E_K) − ḡ_L(V−E_L)\ndx\u002Fdt = α_x(V)(1−x) − β_x(V)x        for x ∈ {m, h, n}\n```\n**⚠️ The gating variables are the insight**: `m³h` and `n⁴` — activation raised to a power\n(multiple independent gates) times inactivation. **Four coupled nonlinear ODEs producing an\naction potential from first principles.**\n\n**Reduced models**: **FitzHugh–Nagumo** (2D, captures excitability and the phase-plane\ngeometry), **integrate-and-fire** and **Izhikevich** (⚠️ **computationally cheap enough for\nlarge networks, and reproduces most observed spiking patterns with four parameters**).\n\n**Nernst and GHK**:\n```\nE_ion = (RT\u002FzF)·ln([ion]_out\u002F[ion]_in)      ⚠️ ~61.5\u002Fz · log₁₀(ratio) mV at 37 °C\n```\n\n**Cardiac electrophysiology**: ionic models (Luo-Rudy, ten Tusscher, O'Hara-Rudy) coupled\nby the **monodomain or bidomain** reaction-diffusion equation for tissue propagation.\n⚠️ **Reentry and spiral waves are the mechanism of many arrhythmias, and they emerge from\nthe tissue equations, not the cell model.**\n\n**Hemodynamics**: **Windkessel** — the 2-element model is `C dP\u002Fdt + P\u002FR = Q(t)`, a\ncapacitor-resistor analogue of arterial compliance and peripheral resistance.\n**Poiseuille**: `Q = πΔP r⁴\u002F(8µL)` — ⚠️ **the `r⁴` is why a small stenosis has enormous\nconsequence; halving radius cuts flow 16-fold.**\n**Reynolds number** `Re = ρvD\u002Fµ` — ⚠️ **blood flow is mostly laminar (Re \u003C 2000); turbulence\nappears at stenoses and valves and is what a bruit or murmur is.**\n**⚠️ Blood is non-Newtonian** — shear-thinning, with the Fåhræus–Lindqvist effect reducing\napparent viscosity in small vessels.\n\n**Respiratory**: compliance `C = ΔV\u002FΔP`, resistance, the **equation of motion**\n`P = V\u002FC + R·V̇ + PEEP`, and dead space via the Bohr equation.\n",{"name":5,"description":7},"develop","ae32736a1aabddabca5d2c96d665aa0ebc7d8700","src\u002Fvibey_tools\u002Fskills\u002Fplugins\u002Fbiomedical-engineering-technical\u002Fskills\u002Fbiomed-structural-systems-biology-and-pharmacology",3,"https:\u002F\u002Fgithub.com\u002Fthe-vibey-project\u002Fvibey","https:\u002F\u002Fthe-vibey-project.github.io\u002Fvibey\u002F","https:\u002F\u002Fgithub.com\u002Fthe-vibey-project","https:\u002F\u002Fvibewithadam.matthewsteinberger.com","freedom for software engineers","2026-11-15 05:47:42",{"source":8,"skillName":5,"commands":35,"prompt":45,"zipAvailable":46},[36,39,42],{"tool":37,"command":38},"npx","npx skills add the-vibey-project\u002Fvibey --skill biomed-structural-systems-biology-and-pharmacology",{"tool":40,"command":41},"bunx","bunx skills add the-vibey-project\u002Fvibey --skill biomed-structural-systems-biology-and-pharmacology",{"tool":43,"command":44},"pnpm","pnpm dlx skills add the-vibey-project\u002Fvibey --skill biomed-structural-systems-biology-and-pharmacology","安装技能，技能地址：https:\u002F\u002Fgithub.com\u002Fthe-vibey-project\u002Fvibey\u002Fblob\u002Fdevelop\u002Fsrc\u002Fvibey_tools\u002Fskills\u002Fplugins\u002Fbiomedical-engineering-technical\u002Fskills\u002Fbiomed-structural-systems-biology-and-pharmacology\u002FSKILL.md",true,[],[49,56,63,70,77,84],{"skillNo":50,"name":51,"nameZh":6,"description":52,"descriptionZh":6,"repositoryFullName":8,"ownerLogin":9,"ownerAvatarUrl":10,"ownerAccountNo":11,"ownerDisplayName":12,"repositoryNo":13,"starsCount":14,"licenseSpdxId":15,"licenseFileUrl":6,"sourceHtmlUrl":53,"categories":54,"keywords":55,"publishedAt":19},"01M7AT1FQJAE1FQYAMDTF490Y4","white-paper-writing","Use when writing white papers, technical reports, policy documents, thought leadership pieces, or any long-form authoritative document. Triggers on requests to write, structure, outline, or review white papers, technical reports, position papers, policy briefs, or evidence-driven arguments. Also use for B2B content marketing strategy, technical documentation requiring authority, academic-style reports, or any document that must educate while persuading. Use when someone asks \"how should I structure this\" for a long-form document.","https:\u002F\u002Fgithub.com\u002Fthe-vibey-project\u002Fvibey\u002Fblob\u002Fdevelop\u002Fsrc\u002Fvibey_tools\u002Fskills\u002Fplugins\u002Fwriting-craft\u002Fskills\u002Fwhite-paper-writing\u002FSKILL.md",[],[],{"skillNo":57,"name":58,"nameZh":6,"description":59,"descriptionZh":6,"repositoryFullName":8,"ownerLogin":9,"ownerAvatarUrl":10,"ownerAccountNo":11,"ownerDisplayName":12,"repositoryNo":13,"starsCount":14,"licenseSpdxId":15,"licenseFileUrl":6,"sourceHtmlUrl":60,"categories":61,"keywords":62,"publishedAt":19},"01M7AT16BJRJJKK2MASXRZS76G","prose-technical-mechanics","Use when editing or writing prose at a technical\u002Fmechanical level: choosing between Anglo-Saxon and Latinate diction, placing information in topic vs stress positions, writing periodic vs cumulative sentences, handling sentence rhythm, punctuation as logic, transitions, paragraph structure, or phonesthetics. Use when someone wants to understand WHY prose works or doesn't, not just surface-level style advice. Triggers on word choice, sentence structure, emphasis, rhythm, diction, or any deep writing mechanics question.","https:\u002F\u002Fgithub.com\u002Fthe-vibey-project\u002Fvibey\u002Fblob\u002Fdevelop\u002Fsrc\u002Fvibey_tools\u002Fskills\u002Fplugins\u002Fwriting-craft\u002Fskills\u002Fprose-technical-mechanics\u002FSKILL.md",[],[],{"skillNo":64,"name":65,"nameZh":6,"description":66,"descriptionZh":6,"repositoryFullName":8,"ownerLogin":9,"ownerAvatarUrl":10,"ownerAccountNo":11,"ownerDisplayName":12,"repositoryNo":13,"starsCount":14,"licenseSpdxId":15,"licenseFileUrl":6,"sourceHtmlUrl":67,"categories":68,"keywords":69,"publishedAt":19},"01M7AT0W9HT0ZZ9Y287NW99MR3","prose-mechanics","Use when writing, editing, or analyzing prose style; when trying to avoid generic AI-sounding writing; when applying specific prose styles such as journalistic, academic, narrative, KJV biblical, Hemingway plain, Latinate\u002FJamesian, Orwellian, Augustan, Victorian, Early Modern (Bacon, Browne, Milton), or free indirect discourse; or when coaching someone on writing voice and mechanics. Triggers on any request to improve, analyze, or write in a specific prose style, to fix \"AI-sounding\" writing, to make prose more vivid or concrete, to vary sentence rhythm, or to understand how a particular writer achieves their effects.","https:\u002F\u002Fgithub.com\u002Fthe-vibey-project\u002Fvibey\u002Fblob\u002Fdevelop\u002Fsrc\u002Fvibey_tools\u002Fskills\u002Fplugins\u002Fwriting-craft\u002Fskills\u002Fprose-mechanics\u002FSKILL.md",[],[],{"skillNo":71,"name":72,"nameZh":6,"description":73,"descriptionZh":6,"repositoryFullName":8,"ownerLogin":9,"ownerAvatarUrl":10,"ownerAccountNo":11,"ownerDisplayName":12,"repositoryNo":13,"starsCount":14,"licenseSpdxId":15,"licenseFileUrl":6,"sourceHtmlUrl":74,"categories":75,"keywords":76,"publishedAt":19},"01M7AT0KR635JX66X2X6F3E2CP","narrative-structure","Use when structuring stories, pitches, presentations, white papers, or any persuasive narrative; analyzing the hero's journey in fiction or non-fiction; applying StoryBrand for business communication; designing narrative arcs for thought leadership; or understanding Vogler, Snyder, Propp, or Campbell frameworks. Triggers on any narrative structure, storytelling, pitch structure, StoryBrand, hero's journey, three-act structure, Freytag, Save the Cat, narrative arc, or \"how should I structure this story\u002Fpitch\u002Fpresentation\" request.","https:\u002F\u002Fgithub.com\u002Fthe-vibey-project\u002Fvibey\u002Fblob\u002Fdevelop\u002Fsrc\u002Fvibey_tools\u002Fskills\u002Fplugins\u002Fwriting-craft\u002Fskills\u002Fnarrative-structure\u002FSKILL.md",[],[],{"skillNo":78,"name":79,"nameZh":6,"description":80,"descriptionZh":6,"repositoryFullName":8,"ownerLogin":9,"ownerAvatarUrl":10,"ownerAccountNo":11,"ownerDisplayName":12,"repositoryNo":13,"starsCount":14,"licenseSpdxId":15,"licenseFileUrl":6,"sourceHtmlUrl":81,"categories":82,"keywords":83,"publishedAt":19},"01M7AT0AKGW09NKKZDYBT8VRDE","legal-brief-writing","Use when writing legal briefs, motions, or any court filing; when analyzing judicial cognition and persuasion; when applying elite brief-writing techniques from Roberts, Clement, Kagan, Garner; or when structuring legal arguments for maximum persuasion. Also use for autistic\u002Fneurodivergent advocates who need to understand how their natural communication style maps to elite legal advocacy. Triggers on any legal writing, brief drafting, motion preparation, or legal argument structuring request.","https:\u002F\u002Fgithub.com\u002Fthe-vibey-project\u002Fvibey\u002Fblob\u002Fdevelop\u002Fsrc\u002Fvibey_tools\u002Fskills\u002Fplugins\u002Fwriting-craft\u002Fskills\u002Flegal-brief-writing\u002FSKILL.md",[],[],{"skillNo":85,"name":86,"nameZh":6,"description":87,"descriptionZh":6,"repositoryFullName":8,"ownerLogin":9,"ownerAvatarUrl":10,"ownerAccountNo":11,"ownerDisplayName":12,"repositoryNo":13,"starsCount":14,"licenseSpdxId":15,"licenseFileUrl":6,"sourceHtmlUrl":88,"categories":89,"keywords":90,"publishedAt":19},"01M7AT00VWPS4Q8B5VEMXX9NQT","journal-publishability-criteria","Use whenever a research paper, article or preprint is being written, revised, reviewed or published, and specifically before every publication of docs\u002Fpaper.md. Covers what legitimate journals actually gate on, in order of gating — the editor's desk screen (scope, novelty, package problems), what reviewers judge (methodological soundness, claims the evidence can carry, statistical and qualitative reporting), EQUATOR reporting guidelines, the ICMJE authorship criteria, COPE's view of text recycling, the near-universal generative-AI policy (no AI author, disclosure, author responsibility), TOP 2025 transparency standards, how to verify a journal is legitimate, submitting without an institution, and a pre-submission checklist. Triggers on requests to evaluate, review, prepare or submit a paper, to judge publishability, to write a declarations or data-availability section, to disclose AI use, or to check a journal.","https:\u002F\u002Fgithub.com\u002Fthe-vibey-project\u002Fvibey\u002Fblob\u002Fdevelop\u002Fsrc\u002Fvibey_tools\u002Fskills\u002Fplugins\u002Fwriting-craft\u002Fskills\u002Fjournal-publishability-criteria\u002FSKILL.md",[],[]]